Literature DB >> 1987759

Expression of blood group antigens H-2, Le(y), and sialylated-Le(a) in human colorectal carcinoma. An immunohistochemical study using double-labeling techniques.

H S Cooper1, M J Malecha, C Bass, P L Fagel, Z Steplewski.   

Abstract

In this study, double-labeling immunohistochemistry was used to gain insight into the coexpression or interrelationship between blood group antigens (BGA) that are differentiation antigens in the normal colon, and BGA that are sequential moieties in the same synthetic pathway. Paired-wise Sialylated-Le(a)/Le(y) and H-2/Le(y) was studied. The Sialylated-Le(a) and Le(y) are synthesized from type 1 and type 2 backbones, respectively. In the normal colon, the Le(y) and Sialylated-Le(a) are expressed by cells at the base and surface of the crypt, respectively, representing undifferentiated and differentiated enterocytes. The H-2 is considered oncofetal in nature, and is considered to be the immediate precursor in the synthesis of Le(y). In individual cancers. Sialylated-Lea and Le(y) were detected in different cancer cells within the same malignant glands, separately in different glands, and in different subcellular compartments of the same cell. Both H-2 and Le(y) were coexpressed in the same individual cells in 92% of cancers expressing both these BGA. In 50% of the cancers, the H-2 and Le(y) also were expressed separately in different malignant glands within individual tumors. These findings indicate that, in colorectal cancers, differentiation antigens (Sialylated Le(a) and Le(y)) are expressed by different individual cells within the same malignant gland somewhat, recapitulating the normal colon crypt. Antigens of different backbones occasionally may be expressed in the same cells but within different subcellular compartments. Precursor accumulation is common in cancers, and antigens in the same synthetic pathway are coexpressed in the same cell. The expression of H-2 and Le(y) in different glands (lack of coexpression) may be explained possibly by aberrant synthesis of Le(y) by an alternate pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987759      PMCID: PMC1886064     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Immunohistologic pattern of type 1 (Lea, Leb) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae.

Authors:  R Mollicone; J Bara; J Le Pendu; R Oriol
Journal:  Lab Invest       Date:  1985-08       Impact factor: 5.662

2.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

3.  Expression of carbohydrate antigen 19-9 and stage-specific embryonic antigen 1 in nontumorous and tumorous epithelia of the human colon and rectum.

Authors:  E Gong; S Hirohashi; Y Shimosato; M Watanabe; Y Ino; S Teshima; S Kodaira
Journal:  J Natl Cancer Inst       Date:  1985-09       Impact factor: 13.506

4.  Biosynthesis of the cancer-associated sialyl-Lea antigen.

Authors:  G C Hansson; D Zopf
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

5.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

Authors:  J L Magnani; B Nilsson; M Brockhaus; D Zopf; Z Steplewski; H Koprowski; V Ginsburg
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

6.  Blood group substances as tumor antigens in the distal colon.

Authors:  H S Cooper; W E Haesler
Journal:  Am J Clin Pathol       Date:  1978-06       Impact factor: 2.493

7.  Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue.

Authors:  M Yuan; S H Itzkowitz; A Palekar; A M Shamsuddin; P C Phelps; B F Trump; Y S Kim
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

8.  Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry.

Authors:  B A Ponder; M M Wilkinson
Journal:  J Histochem Cytochem       Date:  1981-08       Impact factor: 2.479

9.  Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen on large-bowel tumours and normal adult tissues.

Authors:  A Brown; I O Ellis; M J Embleton; R W Baldwin; D R Turner; J D Hardcastle
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

10.  Paired indirect immunoenzyme staining with primary antibodies from the same species. Application of horseradish peroxidase and alkaline phosphatase as sequential labels.

Authors:  K Valnes; P Brandtzaeg
Journal:  Histochem J       Date:  1984-05
View more
  8 in total

1.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

2.  Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression.

Authors:  J Sun; J Thurin; H S Cooper; P Wang; M Mackiewicz; Z Steplewski; M Blaszczyk-Thurin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

3.  Expression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancer.

Authors:  N Fujitani; Y Liu; S Toda; K Shirouzu; T Okamura; H Kimura
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

4.  MAb L9E10 to blood group H2 antigen binds to colon cancer stem cells and inhibits tumor cell migration and invasion.

Authors:  Mai Xu; Fan Wang; Jeffrey C Gildersleeve; Samuel Achilefu
Journal:  Hybridoma (Larchmt)       Date:  2010-08

5.  Intestinal Norovirus Binding Patterns in Nonsecretor Individuals.

Authors:  Georges Tarris; Marie Estienney; Philippe Daval-Frérot; Anne-Cécile Lariotte; Damien Aubignat; Karine Sé; Christophe Michiels; Laurent Martin; Alexis de Rougemont; Gaël Belliot
Journal:  J Virol       Date:  2022-09-19       Impact factor: 6.549

6.  Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.

Authors:  Mizuho Nosaka; Yuko Ishida; Aki Tanaka; Takahito Hayashi; Tomoko Miyashita; Chikako Kaminaka; Wolfgang Eisenmenger; Fukumi Furukawa; Akihiko Kimura
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

7.  Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.

Authors:  C D Katsetos; I Stadnicka; J C Boyd; H Ehya; S Zheng; C M Soprano; H S Cooper; A S Patchefsky; D R Soprano; K J Soprano
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells in vitro.

Authors:  Xiaoying Lei; Chaoxu Liu; Kazem Azadzoi; Cuiling Li; Fan Lu; An Xiang; Jianbin Sun; Yanhai Guo; Qingchuan Zhao; Zhen Yan; Jinghua Yang
Journal:  Sci Rep       Date:  2015-01-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.